Impact of therapeutic drug level monitoring on outcomes of patients with Crohn’s disease treated with Infliximab: real world data from a retrospective single centre cohort study

BACKGROUND: Therapeutic drug monitoring (TDM) by measuring infliximab (IFX) trough levels and antibodies to infliximab (ATI) is used to optimise treatment in inflammatory bowel disease. We aimed to explore the clinical outcomes of TDM for patients with Crohn’s disease on IFX in real life setting. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamperidis, Nikolaos, Middleton, Paul, Tyrrell, Tracey, Stasinos, Ioannis, Arebi, Naila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Colorectal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788274/
https://www.ncbi.nlm.nih.gov/pubmed/31682652
http://dx.doi.org/10.1136/flgastro-2018-101024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788274/
https://www.ncbi.nlm.nih.gov/pubmed/31682652
http://dx.doi.org/10.1136/flgastro-2018-101024

Ejemplares similares